BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang C, Hu J, Li H, Ma H, Othmane B, Ren W, Yi Z, Qiu D, Ou Z, Chen J, Zu X. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. Front Oncol 2021;11:648968. [PMID: 33869048 DOI: 10.3389/fonc.2021.648968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Zhou Y, Zhou X, Huang Y, Cui Y, Zhang Y, Zhuo Z. Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/1146186] [Reference Citation Analysis]
2 Yu D, Pan M, Li Y, Lu T, Wang Z, Liu C, Hu G. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J Exp Clin Cancer Res 2022;41:6. [PMID: 34980207 DOI: 10.1186/s13046-021-02212-1] [Reference Citation Analysis]
3 Cui Y, Zhou Z, Chai Y, Che X, Zhang Y. Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer. J Oncol 2021;2021:8533464. [PMID: 34484338 DOI: 10.1155/2021/8533464] [Reference Citation Analysis]